Medications & Supplements/Prescription Drugs

Bicillin L-A Injectable Suspension Recalled for Visible Particulates

Agency Publication Date: July 30, 2025

Summary

Pfizer Inc. is recalling 70,134 vials of Bicillin L-A (penicillin G benzathine injectable suspension), a prescription antibiotic injection. The recall was issued after visible particulates were found in the medication during a visual inspection, which indicates a deviation from required manufacturing standards. This recall affects both the 1,200,000 units (2 mL) and 2,400,000 units (4 mL) vials manufactured in Austria.

Risk

The presence of foreign particles in an injectable drug poses a risk of local irritation, inflammation, or the blockage of blood vessels. If these particles enter the bloodstream, they could lead to serious systemic health complications.

What You Should Do

This recall affects Bicillin L-A (penicillin G benzathine injectable suspension) antibiotic injections distributed by Pfizer Inc. in 1,200,000 units (2 mL) and 2,400,000 units (4 mL) vials.
Identify the affected products by checking the National Drug Code (NDC) and lot number printed on the vial or carton. Affected 2 mL vials include NDCs 60793-701-10 and 60793-701-02. Affected 4 mL vials include NDCs 60793-702-10 and 60793-702-04. See the Affected Products section below for the full list of affected codes.
Stop using the recalled product immediately. Contact the manufacturer, Pfizer Inc., or your distributor to arrange for the return of any unused medication.
If you have health concerns regarding treatment received with this medication, contact your healthcare provider or pharmacist.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

Other Action

How to: Stop using the recalled product. Contact the manufacturer or your distributor to arrange return.

Affected Products

Product: Bicillin L-A (penicillin G benzathine injectable suspension) (2 mL vial)

Variants: 1,200,000 units per 2 mL

Lot Numbers:

HJ3235 (Exp 09/30/26)

GL2954 (Exp 01/31/27)

HP6222 (Exp 01/31/27)

HR9967 (Exp 05/31/27)

HP6232 (Exp 09/30/27)

LT5190 (Exp 09/30/27)

HP6228 (Exp 10/31/27)

NDC:

60793-701-10

60793-701-02

Rx Only; Distributed by Pfizer Inc.

Product: Bicillin L-A (penicillin G benzathine injectable suspension) (4 mL vial)

Variants: 2,400,000 units per 4 mL

Lot Numbers:

GT2598 (Exp 09/30/26)

GT2599 (Exp 09/30/26)

HK2909 (Exp 02/28/27)

HR9969 (Exp 04/30/27)

HR9984 (Exp 08/31/27)

NDC:

60793-702-10

60793-702-04

Rx Only; Distributed by Pfizer Inc.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97220

Status: Active

Manufacturer: Pfizer Inc.

Sold By: Hospitals; Clinics; Wholesalers; Authorized Medical Distributors

Manufactured In: Austria

Units Affected: 2 products (50,855 2 mL vials; 19,279 vials)

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Bicillin L-A (penicillin G benzathine injectable suspension) antibiotic injections distributed by Pfizer Inc. in 1,200,000 units (2 mL) and 2,400,000 units (4 mL) vials.

Identify the affected products by checking the National Drug Code (NDC) and lot number printed on the vial or carton. Affected 2 mL vials include NDCs 60793-701-10 and 60793-701-02. Affected 4 mL vials include NDCs 60793-702-10 and 60793-702-04. See the Affected Products section below for the full list of affected codes.

Stop using the recalled product immediately. Contact the manufacturer, Pfizer Inc., or your distributor to arrange for the return of any unused medication.

If you have health concerns regarding treatment received with this medication, contact your healthcare provider or pharmacist.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Affected Products

Product: Bicillin L-A (penicillin G benzathine injectable suspension) (2 mL vial)

Variants: 1,200,000 units per 2 mL

Lot Numbers:

HJ3235 (Exp 09/30/26)

GL2954 (Exp 01/31/27)

HP6222 (Exp 01/31/27)

HR9967 (Exp 05/31/27)

HP6232 (Exp 09/30/27)

LT5190 (Exp 09/30/27)

HP6228 (Exp 10/31/27)

NDC:

60793-701-10

60793-701-02

Rx Only; Distributed by Pfizer Inc.

Product: Bicillin L-A (penicillin G benzathine injectable suspension) (4 mL vial)

Variants: 2,400,000 units per 4 mL

Lot Numbers:

GT2598 (Exp 09/30/26)

GT2599 (Exp 09/30/26)

HK2909 (Exp 02/28/27)

HR9969 (Exp 04/30/27)

HR9984 (Exp 08/31/27)

NDC:

60793-702-10

60793-702-04

Rx Only; Distributed by Pfizer Inc.